Review
Published on 13 Jan 2023
Crosstalk between microwave ablation and ferroptosis: The next hot topic?
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1099731
- 3,119 views
- 6 citations
Type at least 3 characters
1,765 articles
Articles
Original Research
Published on 13 Jan 2023
Evaluating the local expression pattern of IGF-1R in tumor tissues and the circulating levels of IGF-1, IGFBP-1, and IGFBP-3 in the blood of patients with different primary bone tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1096438
- 2,259 views
- 3 citations
Case Report
Published on 12 Jan 2023
Exceptional response to alectinib for duodenal carcinoma with ALK fusion: A case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1064944
- 1,470 views
Original Research
Published on 12 Jan 2023
Development of anoikis-related genes signature to predict the prognosis in gastric cancer patients
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1096608
- 3,796 views
- 13 citations
Case Report
Published on 10 Jan 2023
Case report: Acquired neurotrophic tyrosine receptor kinase inhibitor resistance in a patient with pancreatic neuroendocrine carcinoma receiving entrectinib
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1031396
- 1,726 views
Brief Research Report
Published on 10 Jan 2023
Mild oxidative stress protects against chemotherapy-induced hair loss
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1078916
- 2,501 views
- 2 citations
Review
Published on 10 Jan 2023
Potassium channels: Novel targets for tumor diagnosis and chemoresistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1074469
- 5,159 views
- 17 citations
Review
Published on 09 Jan 2023
CircCCDC66: Emerging roles and potential clinical values in malignant tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1061007
- 3,095 views
- 4 citations
Correction
Published on 06 Jan 2023
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1124912
- 1,135 views
Review
Published on 06 Jan 2023
Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1105454
- 3,720 views
- 6 citations
Systematic Review
Published on 05 Jan 2023
Knowledge atlas of antibody-drug conjugates on CiteSpace and clinical trial visualization analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1039882
- 5,598 views
- 10 citations
Original Research
Published on 04 Jan 2023
Crosstalk between protein kinases AKT and ERK1/2 in human lung tumor-derived cell models
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1045521
- 3,231 views
- 5 citations
Original Research
Published on 04 Jan 2023
A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1049183
- 4,019 views
- 11 citations
Brief Research Report
Published on 23 Dec 2022
Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.972322
- 2,122 views
- 3 citations
Original Research
Published on 23 Dec 2022
Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.951589
- 28,073 views
- 25 citations
Review
Published on 22 Dec 2022
The role and mechanism of claudins in cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2022.1051497
- 8,184 views
- 28 citations